石药集团小分子GLP-1授权出海;又一款国产CAR-T疗法获批上市

氨基观察
31 Jul

传统药企持续BD。7月30日,石药集团宣布将小分子GLP-1受体激动剂SYH2086的中国外全球权益授权给Madrigal Pharmaceuticals,后者支付1.2亿美元预付款,19.55亿美元里程碑付款,以及双位数百分比的销售分成。又一款国产CAR-T疗法上市。7月30日,据NMPA官网,恒润达生雷尼基奥仑赛注射液在国内获批上市,用于治疗经过二线或以上系统性治疗后成人复发或难治性大B细胞...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10